|
1.
|
|
10 p, 476.1 KB |
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors
/
Le Tourneau, C. (Paris-Saclay University) ;
Becker, H. (University of Freiburg) ;
Claus, R. (Medical Faculty Augsburg University) ;
Elez, Elena (Vall d'Hebron Institut d'Oncologia) ;
Ricci, F. (Paris-Saclay University) ;
Fritsch, R. (University of Freiburg) ;
Silber, Y. (Medical Faculty Augsburg University) ;
Hennequin, A. (Centre Georges-François Leclerc) ;
Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ;
Jayadeva, G. (Boehringer Ingelheim International GmbH) ;
Luedtke, D. (Boehringer Ingelheim Pharma GmbH and Co KG) ;
He, M. (Boehringer Ingelheim Pharmaceuticals Inc.) ;
Isambert, N. (Centre Georges-François Leclerc) ;
Universitat Autònoma de Barcelona
BI 836880 is a humanized bispecific nanobody® that inhibits vascular endothelial growth factor and angiopoietin-2. Here, we report results from two phase I, nonrandomized, dose-escalation studies (NCT02674152 and NCT02689505; funded by Boehringer Ingelheim) evaluating BI 836880 in patients with confirmed locally advanced or metastatic solid tumors, refractory to standard therapy, or for which standard therapy was ineffective. [...]
2022 -  10.1016/j.esmoop.2022.100576
ESMO open, Vol. 7 (september 2022)
|
|
|
2.
|
|
9 p, 402.4 KB |
Gender influence on work satisfaction and leadership for medical oncologists : a survey of the Spanish Society of Medical Oncology (SEOM)
/
Elez, Elena (Vall d'Hebron Institut d'Oncologia) ;
Ayala de la Peña, Francisco (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ;
García Campelo, Rosario G. (Complexo Hospitalario Universitario) ;
García-Carbonero, Rocío (Hospital Universitario 12 de Octubre (Madrid)) ;
García Donas, J (Centro Integral Oncológico Clara Campal (CIOCC)) ;
González-del-Alba, Aránzazu (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
González-Flores, Encarnación (Hospital Universitario Virgen de las Nieves (Granada)) ;
Hidalgo, Julia (Hospital Lluis Alcanyís de Xativa) ;
Isla, Dolores (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez-Lescure, Álvaro (Hospital General Universitario de Elche) ;
Safont, María José (Consorcio Hospital General Universitario Valencia) ;
Santaballa, Ana (Hospital Universitari i Politècnic La Fe (València)) ;
Villacampa Javierre, Guillermo (Vall d'Hebron Institut d'Oncologia) ;
Vera, Ruth (Complejo Hospitalario de Navarra) ;
Garrido, Pilar (Hospital Universitario Ramón y Cajal (Madrid))
Background: Women represent an increasing proportion of the oncology workforce; however, globally this does not translate into leadership roles, reflecting disparities in career opportunities between men and women. [...]
2021 - 10.1016/j.esmoop.2021.100048
ESMO open, Vol. 6 Núm. 2 (april 2021) , p. 100048
|
|
|
3.
|
|
7 p, 485.5 KB |
Impact of the COVID-19 pandemic on the care of cancer patients in Spain
/
Amador, Mariluz (Asociación Española Contra el Cancer) ;
Matias-Guiu, X. (Hospital Universitari de Bellvitge) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Contreras Martinez, J. (Hospital Regional Universitario de Málaga) ;
de la Torre-Montero, J.C. (Universidad Pontificia Comillas) ;
Peñuelas Saiz, A. (Hospital Universitari Vall d'Hebron) ;
Garrido, P. (Hospital Universitario Ramón y Cajal (Madrid)) ;
García-Sanz, Ramón (Instituto de Investigación Biomédica de Salamanca) ;
Rodríguez-Lescure, None (Hospital Universitario de Elche) ;
Paz-Ares, L. (Hospital Universitario 12 de Octubre (Madrid))
Background: Studies evaluating the effects of the COVID-19 pandemic on public healthcare systems are limited, particularly in cancer management. As no such studies have been carried out in Spain, our objective is to describe and quantify the impact of the COVID-19 pandemic on cancer patients in Spanish hospitals during the first wave of the pandemic. [...]
2021 - 10.1016/j.esmoop.2021.100157
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100157
|
|
|
4.
|
|
14 p, 2.6 MB |
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
/
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Miah, Aisha B. (The Royal Marsden Hospital) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ;
Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ;
Antonescu, Cristina (Memorial Sloan Kettering Cancer Center) ;
Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ;
Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ;
Bauer, Sebastian (University of Duisburg-Essen) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ;
Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ;
Boukovinas, Ioannis P. (Nordix) ;
Bovee, Judith V.M.G. (Leiden University Medical Center) ;
Boye, Kjetil (The Norwegian Radium Hospital) ;
Brodowicz, Thomas (Medical University Vienna) ;
Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ;
Deoras-Sutliff, M. (The EHE Foundation) ;
Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ;
Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ;
Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ;
Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ;
Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ;
Garcia del Muro, Xavier (Universitat de Barcelona) ;
Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ;
Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ;
Gouin, François (Department of Surgery. Centre Leon Berard) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Gutkovich, J. (NUY Langone Medical Center) ;
Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ;
Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ;
Hohenberger, Peter (Mannheim University Medical Center) ;
Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ;
Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ;
Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ;
Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ;
Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ;
Le Cesne, Axel (International Department. Gustave Roussy) ;
Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ;
Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ;
Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ;
Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ;
Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Mir, Olivier (Sarcoma Group. Gustave Roussy) ;
Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ;
Montemurro, Michael (Oncology. CHUV Lausanne) ;
Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ;
Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ;
Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ;
Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ;
Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ;
Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ;
Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ;
Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ;
Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ;
Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ;
Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ;
Schöffski, Patrick (Leuven Cancer Institute) ;
Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Strauss, Sandra J. (University College London Hospital) ;
Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ;
Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ;
Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ;
van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ;
Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ;
van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ;
Wood, J. (The Royal Marsden NHS Foundation Trust) ;
Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ;
Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170
|
|
|
5.
|
|
8 p, 387.2 KB |
Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era : a study of the Spanish Society of Medical Oncology (SEOM)
/
Jiménez-Labaig, P. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Pacheco-Barcia, Vilma (Hospital Central de la Defensa Gomez Ulla) ;
Cebrià, Annabel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Gálvez, F. (Hospital Universitario de Jaén) ;
Obispo, B. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Páez, David (Institut d'Investigació Biomèdica Sant Pau) ;
Quílez, A. (Hospital Can Misses. Área de salud de Ibiza y Formentera (ASEF)) ;
Quintanar, T. (Hospital General Universitario de Elche) ;
Ramchandani, A. (Complejo Hospitalario Universitario Insular Materno Infantil) ;
Remon, Jordi (Hospital HM Delfos) ;
Rogado, J. (Hospital Universitario Infanta Leonor) ;
Sánchez, D.A. (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Sánchez-Cánovas, M. (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Sanz-García, E. (HM Sanchinarro Hospital-Centro Integral Oncológico Clara Campal (CIOOC)) ;
Sesma, A. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Tarazona, N. (Centro de Investigación Biomédica en Red de Cáncer) ;
Cotés, A. (Hospital General de Elda) ;
González, E. (Hospital Universitario Virgen de las Nieves (Granada)) ;
Bosch-Barrera, J. (Hospital Universitari de Girona Doctor Josep Trueta) ;
Fernández Montes, Ana (Complejo Hospitalario Universitario de Ourense) ;
Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ;
Vera, R. (Clínica Universidad de Navarra) ;
Rodríguez-Lescure, None (Hospital General Universitario de Elche) ;
Elez, Elena (Vall d'Hebron Institut d'Oncologia)
Background: Young oncologists are at particular risk of professional burnout, and this could have a significant impact on their health and care of their patients. The coronavirus disease 2019 (COVID-19) pandemic has forced rapid changes in professionals' jobs and training, with the consequent physical and psychological effects. [...]
2021 - 10.1016/j.esmoop.2021.100215
ESMO open, Vol. 6 Núm. 4 (august 2021) , p. 100215
|
|
|
6.
|
|
20 p, 525.5 KB |
Managing hematological cancer patients during the COVID-19 pandemic : an ESMO-EHA Interdisciplinary Expert Consensus
/
Buske, Christian (University Hospital of Ulm (Alemanya)) ;
Dreyling, M. (Department of Medicine III at LMU Hospital) ;
Álvarez Larrán, Alberto (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Apperley, Jane (Imperial College London) ;
Arcaini, Luca (University of Pavia) ;
Besson, Caroline (UVSQ. Inserm. CESP) ;
Bullinger, Lars (Charité - Universitätsmedizin Berlin) ;
Corradini, Paolo (University of Milan) ;
Della Porta, Matteo Giovanni (Humanitas University) ;
Dimopoulos, Meletios (National and Kapodistrian University of Athens) ;
D'Sa, Shirley (University College London Hospitals NHS Foundation Trust) ;
Eich, H.T. (University of Muenster) ;
Foà, R. (Sapienza University) ;
Ghia, P. (Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele) ;
da Silva, M.G. (Portuguese Institute of Oncology) ;
Gribben, J. (Queen Mary University of London) ;
Hajek, Roman (University of Ostrava) ;
Harrison, C. (Guy's and St Thomas' NHS Foundation Trust) ;
Heuser, M. (Hannover Medical School) ;
Kiesewetter, Barbara (Medical University of Vienna) ;
Kiladjian, Jean-Jacques (Université de Paris) ;
Kroeger, Nicolaus (University Hospital Hamburg-Eppendorf) ;
Moreau, Philippe (University Hospital Hotel-Dieu) ;
Passweg, Jakob R. (University Hospital Basel (Basilea, Suïssa)) ;
Peyvandi, Flora (University of Milan) ;
Rea, Delphine (Hôpital Saint-Louis) ;
Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Robak, Tadeusz (Medical University of Lodz) ;
San-Miguel, J (Clínica Universidad de Navarra) ;
Santini, Valeria (University of Florence) ;
Sanz, G. (CIBERONC. IS Carlos III) ;
Sonneveld, P. (Erasmus MC Cancer Institute) ;
Von Lilienfeld-Toal, M. (Hans Knöll Institute) ;
Wendtner, Clemens-Martin (Ludwig-Maximilian University) ;
Pentheroudakis, G. (European Society for Medical Oncology) ;
Passamonti, Francesco (University of Insubria)
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. [...]
2022 - 10.1016/j.esmoop.2022.100403
ESMO open, Vol. 7 Núm. 2 (april 2022) , p. 100403
|
|
|
7.
|
|
14 p, 445.0 KB |
Targeting HER2 in non-small-cell lung cancer (NSCLC) : a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
/
Riudavets, M. (Department of Cancer Medicine. Gustave Roussy Cancer Campus) ;
Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ;
Abdayem, P. (Department of Cancer Medicine. Gustave Roussy Cancer Campus) ;
Planchard, D. (Department of Cancer Medicine. Gustave Roussy Cancer Campus)
Non-small-cell lung cancer (NSCLC) harbouring HER2 alterations is now considered a distinct molecular subtype. The activation of HER2 in NSCLC occurs via three mechanisms, i. e. gene mutation (1%-4% of cases), gene amplification (2%-5%) and protein overexpression (2%-30%), with different prognostic and predictive outcomes. [...]
2021 - 10.1016/j.esmoop.2021.100260
ESMO open, Vol. 6 Núm. 5 (october 2021) , p. 100260
|
|
|
8.
|
|
5 p, 332.1 KB |
Biosimilars : a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
/
Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ;
Vyas, Malvika (European Society for Medical Oncology) ;
Giuliani, Rosa (San Camillo Forlanini Hospital) ;
Arnold, Dirk (CUF Hospitals) ;
Cardoso, Fatima (Champalimaud Clinical Center) ;
Casali, Paolo Giovanni (Fondazione IRCCS National Cancer Institute) ;
Cervantes, Andrés (Clinic Hospital) ;
Eggermont, Alexander (Gustave Roussy Cancer Campus Grand Paris) ;
Eniu, Alexandru (Cancer Institute "Ion Chiricuta") ;
Jassem, Jacek (Medical University of Gdansk) ;
Pentheroudakis, George (University of Ioannina) ;
Peters, Solange (Centre Hospitalier Universitaire Vaudois) ;
Rauh, Stefan (Hospital Center Emile Mayrisch) ;
Zielinski, Christoph C. (Medical University of Vienna) ;
Stahel, Rolf A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Voest, Emile (University Hospital Zurich (Suïssa)) ;
Douillard, Jean-Yves (European Society for Medical Oncology) ;
McGregor, Keith (European Society for Medical Oncology) ;
Ciardiello, Fortunato (Second University of Naples) ;
Universitat Autònoma de Barcelona
Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. [...]
2017 - 10.1136/esmoopen-2016-000142
ESMO open, Vol. 1 (january 2017)
|
|
|
9.
|
|
5 p, 324.7 KB |
The European Cancer Patient's Bill of Rights, update and implementation 2016
/
Højgaard, Liselotte (Kobenhavns Universitet) ;
Löwenberg, Bob (Erasmus University Medical Center) ;
Selby, Peter (University of Leeds) ;
Lawler, Mark (European Cancer Concord) ;
Banks, Ian (University of Leeds) ;
Law, Kate (European Cancer Concord) ;
Albreht, Tit (Institut za varovanje zdravja Republike Slovenija) ;
Armand, Jean-Pierre (Gustave Roussy) ;
Barbacid, Mariano (Centro Nacional de Investigaciones Oncológicas) ;
Barzach, Michèle (IHU Strasbourg Board of Trustees) ;
Bergh, Jonas (Karolinska Institutet (Estocolm, Suècia)) ;
Cameron, David (University of Edinburgh) ;
Conte, Pierfranco (Istituto Oncologico Veneto) ;
de Braud, Filippo (National Cancer Institute) ;
de Gramont, Aimery (Institut Hospitalier Franco-Britannique) ;
De Lorenzo, Francesco (European Cancer Patient Coalition) ;
Diehl, Volker (Universität zu Köln) ;
Diler, Sarper (Myeloma Patients Europe) ;
Erdem, Sema (Europa Donna) ;
Geissler, Jan (European Patients Academy on Therapeutic Innovation) ;
Gore-Booth, Jola (EuropaColon) ;
Henning, Geoffrey (EuropaColon) ;
Horgan, Denis (European Alliance for Personalised Medicine) ;
Jassem, Jacek (Medical University of Gdansk) ;
Johnson, Peter (Cancer Research UK) ;
Kaasa, Stein (Norges Teknisk-Naturvitenskapelige Universitet) ;
Kapitein, Peter (Inspire2Live) ;
Karjalainen, Sakari (Association of European Cancer Leagues) ;
Kelly, Joan (Irish Cancer Society) ;
Kienesberger, Anita (Austrian Childhood Cancer Organisation) ;
La Vecchia, Carlo (Universita degli Studi di Milano) ;
Lacombe, Denis (European Organisation for Research and Treatment of Cancer) ;
Lindahl, Tomas (Francis Crick Institute) ;
Luzzatto, Lucio (Universita degli Studi di Firenze) ;
Malby, Rebecca (London South Bank University) ;
Mastris, Ken (Europa Uomo) ;
Meunier, Françoise (European Organisation for Research and Treatment of Cancer) ;
Murphy, Martin (Society for Translational Oncology) ;
Naredi, Peter (European Cancer Organisation) ;
Nurse, Paul (Francis Crick Institute) ;
Oliver, Kathy (International Brain Tumour Alliance) ;
Pearce, Jonathan (Lymphoma Association) ;
Pelouchov, Jana (European Cancer Patient Coalition) ;
Piccart, Martine (Institut Jules Bordet) ;
Pinedo, Bob (VuMC Cancer Center) ;
Spurrier-Bernard, Gilly (Melanoma Patient Network Europe) ;
Sullivan, Richard (Kings Health Partners Integrated Cancer Centre) ;
Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ;
Van de Velde, Cornelis (Leids Universitair Medisch Centrum) ;
van Herk, Bert (Spaarne Gasthuis) ;
Vedsted, Peter (Aarhus Universitet) ;
Waldmann, Anita (Leukaemiehilfe RHEIN-MAIN) ;
Weller, David (University of Edinburgh) ;
Wilking, Nils (Skåne University Hospital (Suècia)) ;
Wilson, Roger (Sarcoma Patients EuroNet EV) ;
Yared, Wendy (Association of European Cancer Leagues) ;
Zielinski, Christoph C (European Society for Medical Oncology) ;
zur Hausen, Harald (University of Heidelberg) ;
Le Chevalier, Thierry (Institute Gustave Roussy) ;
Johnston, Patrick (European Cancer Concord) ;
Universitat Autònoma de Barcelona
In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative: The key aspects of working towards implementing the BoR are:.
2017 - 10.1136/esmoopen-2016-000127
ESMO open, Vol. 1 (january 2017)
|
|
|
10.
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
